English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/111763
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs

AuthorsGarcía-Moreno, Elena; Gascón, Sonia; Atrián-Blasco, Elena ; Rodríguez-Yoldi, Mª. Jesus; Cerrada, Elena ; Laguna, Mariano
KeywordsAntitumor properties
PTA
Gold
Thiolate
Water soluble
Issue Date2014
PublisherElsevier
CitationEuropean Journal of Medicinal Chemistry 79: 164-172 (2014)
AbstractNew stable thiolate gold(I) derivatives containing the alkylated phosphanes [PTA-CH2Ph]Br and [PTA-CH2COOMe]Br derived from 1,3,5-triaza-7-phosphaadamantane (PTA) have been prepared by different routes of synthesis. By the use of basic media to deprotonate the corresponding thiol in the former and by transmetallation reactions from tin (IV) complexes, in the later, thus avoiding side reactions on the phosphane. Strong antiproliferative effects are observed for most of the compounds, including the chloro- and bromo precursors with the series of phosphanes derived from PTA, in human colon cancer cell lines (Caco-2, PD7 and TC7 clones). Apoptosis-induced cell death is found for all compounds, being the thiolate derivatives with [PTA-CH2Ph]Br the most effective, as shown by an annexin-V/propidium iodide double-staining assay.©2014 Elsevier Masson SAS. All rights reserved.
URIhttp://hdl.handle.net/10261/111763
DOI10.1016/j.ejmech.2014.04.001
Identifiersdoi: 10.1016/j.ejmech.2014.04.001
issn: 0223-5234
e-issn: 1768-3254
Appears in Collections:(ISQCH) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.